Explanatory Statement
This Amendment No. 7 (this “Amendment”) amends and supplements the statement on Schedule 13D originally filed by the Reporting Persons on August 9, 2021, as amended from time to time (the “Schedule 13D”). Unless otherwise indicated, each capitalized term used but not defined in this Amendment shall have the meaning assigned to such term in the Schedule 13D.
Item 4. | Purpose of Transaction |
Item 4 of the Schedule 13D is hereby amended to include the following:
On July 1, 2024, Cypress Investor Holdings, L.P. (“Cypress Investor”), GPE VIII CCC Co-Investment (Delaware) Limited Partnership (“GPE VIII CCC Co-Investment”) and Advent International GPE VIII-C Limited Partnership, (“Advent International VIII-C” and together with Cypress Investor and GPE VIII CCC Co-Investment, the “Advent Funds”) sold 18,319,076 shares, 6,075,328 shares and 579,391 shares of Common Stock, respectively, for $11.299 per share (the “July 2024 Offering”), pursuant to that certain Underwriting Agreement by and among the Advent Funds, the Issuer and the underwriters (the “June 2024 Underwriting Agreement”). In connection with the July 2024 Offering, the Advent Funds entered into customary “lock-up” agreements with the underwriters, dated June 27, 2024 (the “June 2024 Lock-up Agreements”), pursuant to which the Advent Funds generally agreed, subject to certain exceptions, not to sell, transfer, or otherwise dispose of any shares of Common Stock or securities convertible into, or exchangeable or exercisable for, shares of Common Stock, during the period commencing on June 27, 2024 and ending on July 26, 2024, without prior written consent from at least one of the two underwriters.
The foregoing descriptions of the June 2024 Underwriting Agreement and the June 2024 Lock-up Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of the June 2024 Underwriting Agreement, a copy of which is attached as Exhibit 99.1, and a form of the June 2024 Lock-up Agreement attached as Exhibit A to the June 2024 Underwriting Agreement, both of which are incorporated by reference herein.
Item 5. | Interest in Securities of the Issuer |
Item 5(a)-(c) of the Schedule 13D are hereby amended and restated as follows:
The information set forth or incorporated by reference in Items 2 and 6 of this Statement is incorporated by reference in this Item 5.
| (a) | and (b) The responses of the Reporting Persons to rows (7) through (13) of the cover pages of this Schedule 13D are incorporated herein by reference. As of July 1, 2024, the Reporting Persons beneficially owned in the aggregate 139,342,526 shares of Common Stock, which represents approximately 22.4% of the outstanding shares (based on 621,690,009 shares of Common Stock of the Issuer outstanding as of June 21, 2024, as reported in the Issuer’s prospectus supplement on Form 424(b)(3) filed with the Securities and Exchange Commission on June 28, 2024, the “Outstanding Shares”). |
| (b) | The Reporting Persons directly hold or are attributed beneficial ownership of the reported securities as follows: |
| • | | 102,212,216 shares are held directly by Cypress Investor; |
| • | | 3,232,721 shares are directly held by Advent International VIII-C; |
| • | | 33,897,589 shares are directly held by GPE VIII CCC Co-Investment; |
| • | | Cypress Investment GP, LLC (“Cypress GP”), as general partner of Cypress Investor, may be deemed to beneficially own the 102,212,216 shares held directly by Cypress Investor; |
| • | | GPE VIII GP S.à.r.l (“Advent GP Luxembourg”), as general partner of Advent International VIII-C, may be deemed to beneficially own the 3,232,721 shares held directly by Advent International VIII-C; |